Literature
Prescott Group staff members' contributions to the medical literature include the following publications:
Alzheimer's disease
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
Grossberg GT, Manes F, Allegri RF, et al. CNS Drugs. 2013;27(6):469-478.
Read article at PubMed
Depression
Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.
Montgomery SA, Mansuy L, Ruth A, et al. J Clin Psychiatry. 2013;74(4):363-369.
Read article at PubMed
Hypertension
Beta-blockade: benefits beyond blood pressure reduction?
Cockcroft JR, Pedersen ME. J Clin Hypertens (Greenwich, Conn.). 2012;14(2):112-120.
Read article at PubMed
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD, Weber MA, Basile J, et al. Lancet. 2014;383(9932):1889-1898.
Read abstract at PubMed
Schizophrenia
An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.
Durgam S, Starace A, Li D, et al. Schizophr Res. 2014;152(2-3):450-457.
Read article at PubMed
Bipolar Disorder
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
Durgam S, Starace A, Li D, et al. Bipolar Disord. Jul 24 2014.
Read article at PubMed
Epilepsy
Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review.
Pellock JM, Carman WJ, Thyagarajan V, et al. Neurology. 2012;79(14):1482-1489.
Read article at PubMed
Respiratory
Efficacy of aclidinium bromide 400 mcg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
Fuhr R, Magnussen H, Sarem K, et al. Chest. 2012;141(3):745-752.
Read article at PubMed
Other
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.
Siegfried EC, Jaworski JC, Hebert AA. Am J Clin Dermatol. 2013;14(3):163-178.
Read article at PubMed